Condition

Dedifferentiated Liposarcoma clinical trials and research

• 6Clinical trials
• 5Countries

Newest Dedifferentiated Liposarcoma clinical trials

All recruiting trials (6)

• Combining STC-15 with Toripalimab for Advanced Cancers

  This study is testing whether combining a new cancer drug, STC-15, with toripalimab can help people with advanced cancers feel better and improve their treatment outcomes.

  Recruiting at 11 sites Phase 1/2 STORM Therapeutics LTD · San Francisco, California and 13 other locations · NCT06975293

• Testing mirdametinib with palbociclib for treating liposarcoma

  This study is testing a new combination of two medications, mirdametinib and palbociclib, to see if they can help people with advanced liposarcoma feel better and improve their treatment options.

  Recruiting at 7 sites Phase 1/2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT06843967

• Investigating OKN4395 and Pembrolizumab for Solid Tumors

  This study is testing a new drug called OKN4395, alone and with another drug called pembrolizumab, to see if it can help people with solid tumors who have run out of other treatment options.

  Recruiting at 10 sites Phase 1 Epkin · Beverly Hills, California and 9 other locations · NCT06789172

• Combining two drugs to treat advanced dedifferentiated liposarcoma

  This study is testing if combining two drugs can help people with advanced dedifferentiated liposarcoma who haven't had success with other treatments.

  Recruiting at 4 sites Phase 2 Lund University Hospital · Oslo and 3 other locations · NCT06389799

• Evaluating treatments for non-rhabdomyosarcoma soft tissue sarcoma in young patients

  This study is testing a combination of chemotherapy and radiation to see if it helps young patients with non-rhabdomyosarcoma soft tissue sarcoma live longer without their cancer coming back.

  Recruiting at 7 sites Phase 1/2 St. Jude Children's Research Hospital · Atlanta, Georgia and 6 other locations · NCT06239272

• Using Abemaciclib and Radiation Therapy Before Surgery for High-Risk Retroperitoneal Sarcoma

  This study is testing if taking a medication called abemaciclib along with radiation therapy before surgery can help shrink tumors in patients with high-risk retroperitoneal sarcoma.

  Recruiting Phase 1 University of Washington · Seattle, Washington · NCT06025747

Related topics

Quick answers

How many Dedifferentiated Liposarcoma clinical trials are recruiting right now?

6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (5 trials), Norway (1 trial), Sweden (1 trial), Australia (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 3, Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →